|
業務類別
|
Biotechnology |
|
業務概覽
|
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry. |
| 公司地址
| 343 Allerton Avenue, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 577-3600 |
| 傳真號碼
| +1 888 482-2602 |
| 公司網頁
| https://www.vistagen.com |
| 員工數量
| 57 |
| Mr. Shawn K. Singh, J.D. |
President, Chief Executive Officer and Director |
美元 650.00K |
28/07/2025 |
| Mr. Nick B. Tressler |
Principal Accounting Officer, Chief Financial Officer and Treasurer |
-- |
03/12/2025 |
| Ms. Elissa S. Cote |
Chief Corporate Development Officer |
-- |
25/06/2025 |
| Mr. Joshua S. Prince, M.B.A. |
Chief Operating Officer |
美元 410.00K |
28/07/2025 |
| Mr. Reid G. Adler, J.D. |
Chief Legal Officer |
美元 450.00K |
28/07/2025 |
|
|
| Mr. Shawn K. Singh, J.D. |
President, Chief Executive Officer and Director |
28/07/2025 |
| Mr. Jon S. Saxe, J.D.,L.L.M. |
Independent Director |
28/07/2025 |
| Ms. Ann M. Cunningham, M.B.A. |
Director |
28/07/2025 |
| Dr. Joanne Curley, PhD |
Independent Director |
28/07/2025 |
| Ms. Margaret M. FitzPatrick, M.A. |
Chairman of the Board |
28/07/2025 |
|
|
|
|
